Sisters in Health: A Weight Loss Study for African American Women
NCT ID: NCT02631018
Last Updated: 2017-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
84 participants
INTERVENTIONAL
2016-03-31
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The STRENGTH Study: Shapely Sisters Targeting Realistic Exercise and Nutrition Goals Through Healthy Habits
NCT02253641
Community Based Obesity Prevention Among Black Women
NCT00938535
Weight Management Skills in African American Outpatients
NCT00146081
Black Women's Wellness Project
NCT04063059
Weight Loss Counseling for African American Women Who Are Breast Cancer Survivors
NCT00872677
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Interventions to reduce overweight and obesity through lifestyle change have been less effective for AA women compared to NHW women. African American women tend to lose less weight in standard behavioral weight loss interventions. A potential reason for smaller weight loss is that compared to NHW women, AA women have been shown to engage in less physical activity (PA) during these interventions.
The Sisters in Health study will test the efficacy of a 6-month randomized controlled trial in overweight and obese African American women. Women will be recruited to participate in this study comparing a standard behavioral weight loss intervention (BWI) to a physical activity enhanced BWI (BWI-PA) for 6 months. The primary objective of this study is to determine if AA women randomized to the BWI-PA will experience greater weight loss and PA compared to women receiving the BWI. Women in both groups will receive 18 face-to-face sessions on a tapered basis (weekly to biweekly). Face-to-face sessions will provide women with the knowledge, behavioral skills and strategies for weight loss.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Physical Activity Enhanced Weight Loss Intervention
Participants will engage in 18 weight loss intervention group sessions over 6 months. Sessions will occur weekly for the first 3 months, and biweekly for the latter 3 months. Participants will receive a behavioral weight loss curriculum, calorie and physical activity recommendations. This arm, uniquely, will receive a culturally based physical activity component.
Physical Activity Enhanced Weight Loss Intervention
18 session, group-based, 6-month, physical activity enhanced behavioral weight loss intervention
Standard Weight Loss Intervention
Participants will engage in 18 weight loss intervention group sessions over 6 months. Sessions will occur weekly for the first 3 months, and biweekly for the latter 3 months. Participants will receive a behavioral weight loss curriculum, calorie and physical activity recommendations.
Standard Weight Loss Intervention
18 session, group-based, 6-month, standard behavioral weight loss intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard Weight Loss Intervention
18 session, group-based, 6-month, standard behavioral weight loss intervention
Physical Activity Enhanced Weight Loss Intervention
18 session, group-based, 6-month, physical activity enhanced behavioral weight loss intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to read, write, and speak English
* Female gender
* African American/Black/African/Afro-Caribbean race (self-identified)
* BMI 25-45 (\> 45 may have greater risks while participating)
* Meets criteria for low active (defined as \<3 days/week of at most 20 min. of PA/day) assessed by X
* Willingness to be randomized
* Willingness to participate for 6 months, including attending face-to-face sessions \& outside of session tasks
* Access to a computer reliable internet access
* Willingness to use an app for diet and physical activity monitoring
* Regularly used email address
* Not planning to relocate
* Able to attend group sessions on scheduled day
Exclusion Criteria
* Currently participating in another weight loss or PA study, or taking weight loss medication, and unwilling to discontinue those activities
* Pregnant or planning to become pregnant
* Any physical limitations to engaging in or increasing physical activity/exercise- assessed by PAR-Q (including but not limited to heart attack/myocardial infarction, congestive heart failure)
* Type 2 diabetes being treated with insulin
* Major psychological disorder
* History of diagnosed eating disorder
* Medications that affect weight (determined by study staff)
21 Years
65 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Academy of Nutrition and Dietetics
OTHER
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Loneke T. Blackman Carr
Doctoral Candidate
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Deborah F. Tate, PhD
Role: STUDY_CHAIR
University of North Carolina, Chapel Hill
Loneke T. Blackman Carr, MA, RD
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-0484
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.